Crossover Study to Assess the Bioequivalence of Hydrocodone Bitartrate Extended-Release Tablet

Study Title
A Crossover Study to Assess the Bioequivalence of Hydrocodone Bitartrate Extended-Release Tablet
Teva Identifier
C33237/1106
ClinicalTrials.gov Identifier
NCT01758978
Study Status
Completed
Trial Condition(s)
Pain
Interventions
Drug: a 60 mg dose of the hydrocodone bitartrate extended-release tablet administered as either two 30-mg tablets (Treatment A) or one 60-mg tablet (Treatment B).

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age group
Adult
Age Range
18 Years to 45 Years
Trial Duration
12/01/2012 - 01/01/2013
Phase
Phase 1

Study Type

Interventional